Publications by authors named "Danny Houtsma"

Claim this Profile
H
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial.
Noor Wortelboer, Seamus Kent, Inge R Konings, Annemiek van Ommen-Nijhof, Vincent van der Noort, Danny Houtsma

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups.
Karel C Smit, Jeroen W G Derksen, Anne-Sophie van Lanen, Evertine Wesselink, Eric J Th Belt, Danny Houtsma

JNCI Cancer Spectr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.
Karan Parekh, Kim van der Zande, Sarah W S Ng, Cameron Herberts, Edmond M Kwan, Danny Houtsma

Eur Urol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01).
Anne F de Groot, Danielle Cohen, Joan B Heijns, Caroline M P W Mandigers, Agnes J van de Wouw, Danny Houtsma

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.
Eshwari Dathathri, Fikri Abali, Michiel Stevens, Richell Booijink, Tanja C van Dijk, Danny Houtsma

Cancer Res Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Joosje C Baltussen, Frederiek van den Bos, Marije Slingerland, Trishika R R Binda, Gerrit-Jan Liefers, Danny Houtsma

BMJ Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer.
Joosje C Baltussen, Simon P Mooijaart, Annelie J E Vulink, Danny Houtsma, Wendy M Van der Deure

Breast Cancer Res Treat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis.
Karel C Smit, Jeroen W G Derksen, Rebecca K Stellato, Anne-Sophie VAN Lanen, Evertine Wesselink, Danny Houtsma

Med Sci Sports Exerc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Birgit S Geurts, Thomas W Battaglia, J Maxime van Berge Henegouwen, Laurien J Zeverijn, Gijs F de Wit, Danny Houtsma

BMC Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.
Rieneke T Lugtenberg, Stefanie de Groot, Danny Houtsma, Vincent O Dezentjé, Annelie J E Vulink

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.
Bert N Storm, Hanieh Abedian Kalkhoran, Erik B Wilms, Pepijn Brocken, Henk Codrington, Danny Houtsma

J Geriatr Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Rieneke T Lugtenberg, Corina J G van den Hurk, Carolien H Smorenburg, Linda Mosch, Danny Houtsma

Support Care Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients.
Emma C Hulshof, Mirjam de With, Femke M de Man, Geert-Jan Creemers, Birgit A L M Deiman, Danny Houtsma

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.
Vera van der Zanden, Neeltje J van Soolingen, Alain R Viddeleer, Johannes W Trum, Frédéric Amant, Danny Houtsma

Gynecol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
Saskia Lisa Verhaart, Yasmin Abu-Ghanem, Sasja F Mulder, Sjoukje Oosting, Astrid Van Der Veldt, Danny Houtsma

Clin Genitourin Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
Danny Houtsma, Stefanie de Groot, Renee Baak-Pablo, Elma Meershoek-Klein Kranenbarg, Caroline M Seynaeve

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis